Concord Biotech Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Jun '24
Mar '24
Dec '23
Sep '23
Jun '23
Total Qtr Revenue cr
226.11
329.78
248.98
270.47
201.48
Other Income Qtr Cr10.3110.818.198.136.65
Operating Revenues Qtr215.80318.97240.80262.35194.83

*All values are in Cr.

Operating Expenses Qtr
134.52
184.68
134.87
143.16
122.68
Operating Profit Qtr
81.28
134.29
105.93
119.19
72.15
EBIDT Qtr Cr
91.59
145.10
114.12
127.32
78.81
Depreciation Qtr
13.18
13.72
13.54
13.30
13.04
Net Profit Qtr
59.59
95.02
77.57
81.02
54.49
Basic EPS Qtr
5.70
9.08
7.41
7.74
5.21
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -